309 related articles for article (PubMed ID: 15504992)
1. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function.
Li Y; Xu W; Liao Z; Yao B; Chen X; Huang Z; Hu G; Weng J
Diabetes Care; 2004 Nov; 27(11):2597-602. PubMed ID: 15504992
[TBL] [Abstract][Full Text] [Related]
2. Insulin requirement profiles of short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes and its association with long-term glycemic remission.
Liu L; Ke W; Wan X; Zhang P; Cao X; Deng W; Li Y
Diabetes Res Clin Pract; 2015 May; 108(2):250-7. PubMed ID: 25765670
[TBL] [Abstract][Full Text] [Related]
3. Remission of hyperglycemia following intensive insulin therapy in newly diagnosed type 2 diabetic patients: a long-term follow-up study.
Xu W; Li YB; Deng WP; Hao YT; Weng JP
Chin Med J (Engl); 2009 Nov; 122(21):2554-9. PubMed ID: 19951569
[TBL] [Abstract][Full Text] [Related]
4. [The effects of early intensive therapy on islet beta cell function and long-term glycemia control in newly diagnosed type 2 diabetic patients with different fasting plasma glucose levels.].
Li YB; Zeng LY; Shi LX; Zhu DL; Zhou ZG; Yan L; Tian HM; Luo ZJ; Yang LY; Liu J; Weng JP
Zhonghua Nei Ke Za Zhi; 2010 Jan; 49(1):9-13. PubMed ID: 20356473
[TBL] [Abstract][Full Text] [Related]
5. [Influencing factors for the curative effects of short-term continuous subcutaneous insulin infusion on newly diagnosed type 2 diabetes].
Li YB; Zhu HL; Yao B; Huang ZM; Ou XZ; Xiao YB; Weng JP
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):602-5. PubMed ID: 15949356
[TBL] [Abstract][Full Text] [Related]
6. Fasting plasma glucose after intensive insulin therapy predicted long-term glycemic control in newly diagnosed type 2 diabetic patients.
Liu J; Liu J; Fang D; Liu L; Huang Z; Wan X; Cao X; Li Y
Endocr J; 2013; 60(6):725-32. PubMed ID: 23428844
[TBL] [Abstract][Full Text] [Related]
7. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment.
Ilkova H; Glaser B; Tunçkale A; Bagriaçik N; Cerasi E
Diabetes Care; 1997 Sep; 20(9):1353-6. PubMed ID: 9283777
[TBL] [Abstract][Full Text] [Related]
8. [The effect and mechanism of transient continuous subcutaneous insulin infusion therapy on beta cell function, insulin resistance and vascular endothelial injury in newly diagnosed type 2 diabetes].
Liu SP; Mo H; Liu BL; Tang WL; Deng XG; Su X; Yao L; Lin J; Feng Q; Peng J; Zhou ZG; Li YJ
Zhonghua Nei Ke Za Zhi; 2010 May; 49(5):405-9. PubMed ID: 20646415
[TBL] [Abstract][Full Text] [Related]
9. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
Weng J
J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
[TBL] [Abstract][Full Text] [Related]
10. [Characteristics of dysfunction of islet beta-cell in newly diagnosed type 2 diabetic patients].
Li YB; Zhu DL; Tian HM; Shi LX; Luo ZJ; Yan L; Zeng LY; Zhou ZG; Yang LY; Liu J; Li M; Weng JP
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2537-41. PubMed ID: 17198561
[TBL] [Abstract][Full Text] [Related]
11. Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy.
Liu L; Wan X; Liu J; Huang Z; Cao X; Li Y
Diabetes Technol Ther; 2012 Sep; 14(9):756-61. PubMed ID: 22731793
[TBL] [Abstract][Full Text] [Related]
12. Improvement of β-cell function after achievement of optimal glycaemic control via long-term continuous subcutaneous insulin infusion therapy in non-newly diagnosed type 2 diabetic patients with suboptimal glycaemic control.
Choi SB; Lee JH; Lee JH; Kim S; Han SD; Kim IH; Noh YH
Diabetes Metab Res Rev; 2013 Sep; 29(6):473-82. PubMed ID: 23592489
[TBL] [Abstract][Full Text] [Related]
13. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
Yu JG; Kruszynska YT; Mulford MI; Olefsky JM
Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
[TBL] [Abstract][Full Text] [Related]
14. Short-term continuous subcutaneous insulin infusion combined with insulin sensitizers rosiglitazone, metformin, or antioxidant α-lipoic acid in patients with newly diagnosed type 2 diabetes mellitus.
Huang Z; Wan X; Liu J; Deng W; Chen A; Liu L; Liu J; Wei G; Li H; Fang D; Li Y
Diabetes Technol Ther; 2013 Oct; 15(10):859-69. PubMed ID: 23991629
[TBL] [Abstract][Full Text] [Related]
15. Noninferiority effects on glycemic control and β-cell function improvement in newly diagnosed type 2 diabetes patients: basal insulin monotherapy versus continuous subcutaneous insulin infusion treatment.
Zeng L; Lu H; Deng H; Mu P; Li X; Wang M
Diabetes Technol Ther; 2012 Jan; 14(1):35-42. PubMed ID: 21877913
[TBL] [Abstract][Full Text] [Related]
16. The effects of short-term continuous subcutaneous insulin infusion treatment on fasting glucagon-like peptide-1 concentrations in newly diagnosed type 2 diabetes.
Huang X; Li S; Yang M; Fu X; Li H; Yan T; Liu Y; Chen L; Lan L; Li L; Zhong X
Diabetes Res Clin Pract; 2018 Apr; 138():246-252. PubMed ID: 29408704
[TBL] [Abstract][Full Text] [Related]
17. Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes.
Glaser B; Leibovich G; Nesher R; Hartling S; Binder C; Cerasi E
Acta Endocrinol (Copenh); 1988 Jul; 118(3):365-73. PubMed ID: 3293339
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Long-Term Glycemic Remission After 2-Week Intensive Insulin Treatment in Newly Diagnosed Type 2 Diabetes.
Wang H; Kuang J; Xu M; Gao Z; Li Q; Liu S; Zhang F; Yu Y; Liang Z; Zhao W; Yang G; Li L; Wang Y; Li G
J Clin Endocrinol Metab; 2019 Jun; 104(6):2153-2162. PubMed ID: 30629195
[TBL] [Abstract][Full Text] [Related]
19. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.
Weng J; Li Y; Xu W; Shi L; Zhang Q; Zhu D; Hu Y; Zhou Z; Yan X; Tian H; Ran X; Luo Z; Xian J; Yan L; Li F; Zeng L; Chen Y; Yang L; Yan S; Liu J; Li M; Fu Z; Cheng H
Lancet; 2008 May; 371(9626):1753-60. PubMed ID: 18502299
[TBL] [Abstract][Full Text] [Related]
20. Effects of Liraglutide Combined with Short-Term Continuous Subcutaneous Insulin Infusion on Glycemic Control and Beta Cell Function in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Pilot Study.
Ke W; Liu L; Liu J; Chen A; Deng W; Zhang P; Cao X; Liao Z; Xiao H; Liu J; Li Y
J Diabetes Res; 2016; 2016():6839735. PubMed ID: 26640805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
